AvePoint insider plans sale of 60,000 shares
Form 144 discloses a planned sale of 60,000 shares of common stock of the issuer through The Charles Schwab Corporation, with an approximate sale date of 01/12/2026 on the NASDAQ.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Form 144 discloses a planned sale of 60,000 shares of common stock of the issuer through The Charles Schwab Corporation, with an approximate sale date of 01/12/2026 on the NASDAQ. The shares to be sold are described as founders shares, acquired from the issuer on 01/02/2006, with 215,789,313 common shares stated as outstanding. The notice also lists recent sales by Xunkai Gong, including multiple common stock transactions in November and December 2025 with disclosed gross proceeds for each sale.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does this Form 144 filing for AVPT disclose?
Who is the selling security holder in this AVPT Form 144?
What recent AVPT stock sales by the filer are disclosed?
AI-generated analysis. How Rhea-AI works. Not financial advice.